← All trials
NCT05762510
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2023
- Primary completion
- Apr 1, 2028
- Completion date
- Oct 31, 2030
- First posted
- Mar 9, 2023
- Last posted
- May 9, 2023
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hacettepe UniversityLead sponsor
- Hacettepe UniversityReponsible party - principal investigator
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.